Join the team dedicated to Oncology, with an ambition to eliminate cancer as a cause of death. It's our vision that unites and inspires us.
With indications and high-quality molecules at all stages of our pipeline, we keep pushing forward. Fusing ground breaking science with the latest technology to achieve breakthroughs. Backed by investment, we are seeking to deliver 6 new molecular entities by 2025.